Edwards Lifesciences (EW) Tops Q4 EPS by 3c, Offers Q1 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Northland Capital Remains Positive on Edwards Lifesciences (EW) Long-Term Outlook
February 2, 2017 12:50 PM ESTNorthland Capital Markets analyst Suraj Kalia is sticking with her Outperform rating and $105 price target on Edwards Lifesciences (NYSE: EW) even though the company is hard time meeting lofty Street expectations.
Kalia commented, "Q4-16 revs @ $768M > consensus @ $758M & our estimate @ $763M. GAAP EPS @ $0.73 > our estimate @ $0.71 &... More
Leerink Partners Downgrades Edwards Lifesciences (EW) to Market Perform
February 2, 2017 9:34 AM ESTLeerink Partners downgraded Edwards Lifesciences (NYSE: EW) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $98.02 yesterday.
... More